HER2+ Breast CancerHER2-Positive
HER2CLIMB
This subgroup brings together the main pages related to the HER2CLIMB regimen.
Use it when you want to understand:
why progression may happen on tucatinib, trastuzumab, and capecitabine
what liquid biopsy may or may not detect
whether tucatinib clearance could be altered
whether supplements may affect CYP3A4-related drug handling
Pages in this section
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.